ArticleCancer chemotherapy and pharmacology2021
Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results.
Clotilde Gaible et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it